Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
Sexual & Reproductive Health Drugs Market by Drugs Type (Erectile Dysfunction Drugs, Gender Dysphoria Drugs, Hypoactive Sexual Desire Disorder Drugs), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Global Forecast 2024-2030
... Reproductive Health Drugs Market size was estimated at USD 31.64 billion in 2023 and expected to reach USD 35.83 billion in 2024, at a CAGR 13.34% to reach USD 76.03 billion by 2030. Global Sexual ... Read More
-
Analgesics Market by Drug Type (Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, Salicylates), Type (Non-Opioids, Opioids), Route of Administration, Distribution - Global Forecast 2024-2030
... to reach USD 23.75 billion in 2024, at a CAGR 8.79% to reach USD 39.42 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Analgesics Market. It offers a ... Read More
-
Medication Management System Market by Software (Administration Software, Automated Dispensing Systems, Clinical Decision Support System Solutions), Service (ADE Surveillance, Medication Analytics, Point-of-Care Verification), Mode of Delivery, End-Use -
... Market size was estimated at USD 3.74 billion in 2023 and expected to reach USD 4.25 billion in 2024, at a CAGR 14.35% to reach USD 9.56 billion by 2030. FPNV Positioning Matrix The FPNV ... Read More
-
Rheumatology Therapeutics Market by Indication (Ankylosing Spondylitis, Gout, Osteoarthritis), Distribution Channel (Offline Mode, Online Stores) - Global Forecast 2024-2030
... reach USD 33.24 billion in 2024, at a CAGR 6.51% to reach USD 48.58 billion by 2030. Global Rheumatology Therapeutics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Rheumatology Therapeutics ... Read More
-
Pleurodynia Treatment Market by Diagnosis (Blood Test, Culture Test, X-ray), Treatment (Analgesics, Immunoglobulin), Mode Of Administration, End-User - Global Forecast 2024-2030
... expected to reach USD 145.40 million in 2024, at a CAGR 5.66% to reach USD 203.54 million by 2030. Global Pleurodynia Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Vulvodynia Treatment Market by Type (Biofeedback & Physical Therapy, Intralesional Injections, Oral Treatment), Indication (Generalized Vulvodynia, Localized Vulvodynia), Providers - Global Forecast 2024-2030
... 2023 and expected to reach USD 60.82 billion in 2024, at a CAGR 9.62% to reach USD 105.67 billion by 2030. Global Vulvodynia Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Diuretics Drugs Market by Drug Type (Calcium Sparing Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics), Distribution Channel (Drug Stores, Hospital Pharmacies, Online Pharmacies), Route of Administration, Applications - Global Forecast 2024-2030
... was estimated at USD 1.19 billion in 2023 and expected to reach USD 1.29 billion in 2024, at a CAGR 8.54% to reach USD 2.12 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Muscle Relaxants Drug Market by Drug (Facial Muscle Relaxant, Neuromuscular Relaxant, Skeletal Muscle Relaxant), Distribution (Clinics, Drug Stores, Hospitals) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 4.78 billion in 2024, at a CAGR 7.88% to reach USD 7.55 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Muscle ... Read More
-
Postpartum Depression Treatment Market by Treatment Type (Antidepressant Drugs, Psychotherapy), Distribution (Drug Stores, E-Commerce, Hospital Pharmacies) - Global Forecast 2024-2030
... expected to reach USD 1,026.86 million in 2024, at a CAGR 8.74% to reach USD 1,705.58 million by 2030. Global Postpartum Depression Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Emergency Contraceptive Pills Market by Type (Antiprogestin, Combination Pills, Progesterone Pills), Category (Branded, Generic), Age Group, Distribution - Global Forecast 2024-2030
... and expected to reach USD 1.08 billion in 2024, at a CAGR 6.49% to reach USD 1.58 billion by 2030. Emergency contraceptive pills, commonly called the “morning-after pill,” are a type of birth control method ... Read More
-
Cold Pain Therapy Market by Product (OTC Products, Prescription Products), Distribution Channel (E-commerce, Hospital Pharmacy, Retail Pharmacy), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.22 billion in 2024, at a CAGR 8.20% to reach USD 3.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cold Pain ... Read More
-
Opioid Induced Constipation Market by Active Ingredients (Bulk Cathartics, Stimulant Cathartics, Docusate Sodium, Emollient/Lubricant Cathartics), Drug Class (Locally Acting Chloride Channel Activator (LACCA), Non-Selective Opioid Antagonist, Peripherally
... Channel - Global Forecast 2024-2030 The Opioid Induced Constipation Market size was estimated at USD 65.95 million in 2023 and expected to reach USD 70.10 million in 2024, at a CAGR 6.69% to reach USD ... Read More
-
Anti-Obesity Drugs Market by Drug Type (Over-The-Counter Drugs, Prescription Drugs), Mechanism of Action (Centrally Acting Drugs, Peripherally Acting Drugs) - Global Forecast 2024-2030
... 2023 and expected to reach USD 4.09 billion in 2024, at a CAGR 6.86% to reach USD 6.10 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-Obesity Drugs ... Read More
-
Women's Health Market by Age (13-17 Years, 18-35 Years, 36 Years & Above), Distribution Channel (Hospital, Online, Retail), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 46.99 billion in 2024, at a CAGR 8.97% to reach USD 78.90 billion by 2030. Global Women's Health MarketThe women's health market includes diagnosis, treatments, medications, surgical procedures, and ... Read More
-
Anti-obesity Prescription Drugs Market by Drug Class (Bupropion & Naltrexone, Liraglutide, Lorcaserin), Age Group (Adult, Pediatric), Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 6.71 billion in 2024, at a CAGR 8.12% to reach USD 10.74 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-obesity Prescription ... Read More
-
Anti-Obesity Therapeutics Market by Treatment Type (Medications, Treatments), End-use (Ambulatory Surgical Centers, Hospitals, Specialty Clinics) - Global Forecast 2024-2030
... reach USD 10.81 billion in 2024, at a CAGR 8.44% to reach USD 17.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-Obesity Therapeutics Market. It offers a ... Read More
-
Antipsychotic Drugs Market by Class (First Generation, Second Generation, Third Generation), Indication (Bipolar Disorders, Dementia, Schizophrenia) - Global Forecast 2024-2030
... to reach USD 10.42 billion in 2024, at a CAGR 8.01% to reach USD 16.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Antipsychotic Drugs Market. It offers ... Read More
-
Digital Pharmacy Market by Drug Type (Over-The-Counter Drugs, Prescription Drugs), Platform (Apps, Websites) - Global Forecast 2024-2030
... 164.91 billion in 2024, at a CAGR 19.20% to reach USD 475.08 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Digital Pharmacy Market. It offers a comprehensive assessment ... Read More
-
Long-acting Contraception Market by Type (Long-Acting Contraceptives, Short-Acting Contraceptives), Product (Injectables, Intrauterine Devices, Subdermal Implants), Application, End-use - Global Forecast 2024-2030
... expected to reach USD 3.68 billion in 2024, at a CAGR 7.06% to reach USD 5.52 billion by 2030. Global Long-acting Contraception Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Insomnia Drugs Market by Type (Anti-Parkinsonian Drugs, Anticonvulsants, Antidepressants), Distribution Channels (Online Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
... reach USD 3.07 billion in 2024, at a CAGR 5.67% to reach USD 4.30 billion by 2030. Global Insomnia Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Insomnia Drugs ... Read More
-
Insomnia Pharmacological Treatment Market by Drug (OTC Drugs, OTC Sleep Aids, OTC Sleep Supplements), Treatment (Over-the-Counter Sleep Aids, Prescription Sleep Aids), Distribution Channel - Global Forecast 2024-2030
... at USD 6.58 billion in 2023 and expected to reach USD 7.01 billion in 2024, at a CAGR 7.07% to reach USD 10.62 billion by 2030. Global Insomnia Pharmacological Treatment Market FPNV Positioning Matrix The ... Read More
-
Hormonal Contraceptives Market by Hormone (Androgens, Antiandrogens, Estrogens), Method (Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives), End-user - Global Forecast 2024-2030
... expected to reach USD 18.34 billion in 2024, at a CAGR 6.76% to reach USD 27.19 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Hormonal Contraceptives Market. It ... Read More
-
Smart Drugs & Pills Market by Target Area (Esophagus, Large Intestine, Small Intestine), Type (Over-the-Counter Nootropics, Prescription Nootropics), End User, Application - Global Forecast 2024-2030
... USD 8.28 billion in 2023 and expected to reach USD 10.18 billion in 2024, at a CAGR 24.18% to reach USD 37.71 billion by 2030. Global Smart Drugs & Pills MarketSmart drugs & pills equipped ... Read More
-
Vision Care Market by Product (Cleaning & Disinfecting Solutions, Contact Lenses, Spectacle Lenses), Type (Non-Rx (Non-Prescription), Rx (Prescription)), Distribution Channel - Global Forecast 2024-2030
... in 2023 and expected to reach USD 84.71 billion in 2024, at a CAGR 8.19% to reach USD 136.37 billion by 2030. Global Vision Care Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Calcium Gluconate Market by Form (Liquid, Powder), End-User (Food & Beverage, Personal Care, Pharmaceuticals) - Global Forecast 2024-2030
... USD 817.22 million in 2024, at a CAGR 5.54% to reach USD 1,132.92 million by 2030. Global Calcium Gluconate Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Calcium Gluconate Market. ... Read More
Research Assistance
